Snapshot · Thermo Fisher Scientific Inc. (TMO)

Data as of 2026-10-19T08:14:20.895Z

Fundamentals check

Market cap

$255.1B

P/E (TTM)

37.1

Gross margin

41.0%

Net margin

15.1%

ROE

13.4%

R&D / revenue

3.0%

Dividend yield

0.3%

FCF yield

2.9%

Latest dividend: $0.47/share (ex-date 2026-09-15, quarterly)

Summary

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

How it makes money

Revenue mix, latest fiscal year

• Consumables41.9%
• Service41.7%
• Instruments16.4%

Recent Events

• 2026-10-15T00:00:00.000Zpositive

  Price move: TMO rose 3.5%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-10-13T13:25:00.000Zneutral

  Thermo Fisher to Report Q3 Earnings: What's in the Cards?

  关于季度业绩展望的前瞻性报道，可能影响投资者情绪，但不确定性较高，尚未确定结果。

  Source: Zacks Investment Research

• 2026-10-12T15:00:03.000Zpositive

  All You Need to Know About Thermo Fisher (TMO) Rating Upgrade to Buy

  评级提升报道或许反映分析师对业绩预期乐观，可能与股价短期走势相关，但不构成因果。

  Source: Zacks Investment Research

• 2026-10-06T02:00:00.000Zpositive

  Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026

  恰逢在米兰展会展示新解决方案，可能与TMO的产品能力扩展相关，市场影响存在不确定性。

  Source: businesswire.com

• 2026-09-15T00:00:00.000Zpositive

  Price move: TMO rose 4.5%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-08-19T00:00:00.000Zpositive

  Price move: TMO rose 4.2%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-23T00:00:00.000Zpositive

  Price move: TMO rose 8.7%

  TMO 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $689 from 12 analysts (last quarter)

Insider & Congress activity

Open-market trades only; grants and exercises excluded

• 2026-08-31SellPettiti Gianluca(officer: President & COO)400 shares
• 2026-08-31SellPettiti Gianluca(officer: President & COO)3,733 shares
• 2026-08-24SellCASPER MARC N(director, officer: Chairman & CEO)62 shares
• 2026-08-24SellCASPER MARC N(director, officer: Chairman & CEO)79 shares
• 2026-08-24SellCASPER MARC N(director, officer: Chairman & CEO)33 shares

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。